1. |
1 Atiyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar: the controversy: review of the literature.
Ann Plast Surg
, 2005, 54(6): 676-680.
|
2. |
2 Menezes HL, Jucá MJ, Gomes EG,
et al
. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
Arq Gastroenterol
, 2010, 47(2): 141-147.
|
3. |
3 Thomas M, Kalita A, Labrecque S,
et al
. Two polymorphic variants of wild-type p53 differ biochemically and biologically.
Mol Cell Biol
, 1999, 19(2): 1092-1100.
|
4. |
11 Sakamuro D, Sabbatini P, White E,
et al
. The polyproline region of p53 is required to activate apoptosis but not growth arrest.
Oncogene
, 1997, 15(8): 887-898.
|
5. |
12 Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Proc Natl Acad Sci U S A
, 1996, 93(26): 15335-15340.
|
6. |
13 Matlashewski GJ, Tuck S, Pim D,
et al
. Primary structure polymorphism at amino acid residue 72 of human p53.
Mol Cell Biol
, 1987, 7(2): 961-963.
|
7. |
14 Thomas M, Kalita A, Labrecque S,
et al
. Two polymorphic variants of wild-type p53 differ biochemically and biologically.
Mol Cell Biol
, 1999, 19(2): 1092-1100.
|
8. |
15 Saed GM, Ladin D, Olson J,
et al
. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.
Arch Dermatol
, 1998, 134(8): 963-967.
|
9. |
王春梅, 百束比古, 中澤南堂. 增生性瘢痕和瘢痕疙瘩p53基因多態性的分析.中華整形外科雜志, 2005, 21(1): 32-35.
|
10. |
呂雅麗, 李俊枝, 米明仁, 等. CBS基因多態性與中國人缺血性腦卒中關系的Meta分析. 中國循證醫學雜志, 2010, 10(6): 674-677.
|
11. |
卓陽. p53、Fas基因多態性與瘢痕疙瘩的相關性研究及基因檢測試劑盒的初步構建. 廣州: 第一軍醫大學, 2005.
|
12. |
靳瑾. 瘢痕疙瘩p53基因檢測試劑盒的臨床應用與評價. 廣州: 南方醫科大學, 2007.
|
13. |
劉勇. 中國漢族瘢痕疙瘩致病基因初步連鎖分析和相關基因多態性的研究. 沈陽: 中國醫科大學, 2007.
|
14. |
卓陽, 高建華, 曾興業, 等. 瘢痕疙瘩p53 基因檢測試劑盒的臨床應用. 中國美容醫學, 2008, 17(5): 694-696.
|
15. |
劉永波. 瘢痕疙瘩成纖維細胞Fas及P53蛋白凋亡缺陷的相關研究. 廣州: 南方醫科大學, 2008.
|
16. |
嚴笠, 呂曉巖, 王春梅, 等. p53基因第72密碼子多態性與部分中國人瘢痕疙瘩關系的研究. 中華整形外科雜志, 2007, 23(5): 428-430.
|